MELD fails to measure quality of life in liver transplant candidates

Liver Transplantation

Volumn 11, Issue 2, 2005, Pages 218-223

  Saab, Sammy ^a   Ibrahim, Ayman B ^a   Shpaner, Alexander ^b   Younossi, Zobair M ^c   Lee, Cindy ^a   Durazo, Francisco ^a   Han, Steven ^a   Esrason, Karl ^d   Wu, Victor ^d   Hiatt, Jonathan ^a   Farmer, Douglas G ^a   Ghobrial, R Mark ^a   Holt, Curtis ^a   Yersiz, Hasan ^a   Goldstein, Leonard I ^a   Tong, Myron J ^a   Busuttil, Ronald W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Inova Fairfax Hospital   (United States)

^d Kaiser Permanente ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; LACTULOSE; NEOMYCIN; QUININE;

ABDOMINAL CRAMP; ADULT; ARTICLE; ASCITES; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; INFORMATION PROCESSING; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36;

FEMALE; HEALTH STATUS INDICATORS; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; TISSUE AND ORGAN PROCUREMENT;

EID: 20944447908     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20345     Document Type: Article

References (26)

1. Freeman RB Jr, Wiesner RH, Harper A, et al., UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8:851-858.
2. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871.
3. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470.
4. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001;7:567-580.
5. Wiesner R, Edwards E, Freeman R, et al., and the United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96.
6. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding esophageal varices. Br J Surg 1973;60:646-654.
7. Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001;96:2199-2205.
8. Younossi ZM, Kiwi ML, Boparai N, Price LL, Guyatt G. Cholestatic liver diseases and health-related quality of life. Am J Gastroenterol 2000;95:497-502.
9. Younossi ZM, Guyatt G, Kiwi M, Moparai N, King D. Development of a disease-specific questionnaire to measure health-related quality of life in patients with chronic liver disease. Gut 1999;45:295-300.
10. Gralnek IM, Hays RD, Kilbourne A, Rosen HR, Keeffe EB, Artinian L, et al. Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease - the LDQOL 1.0. Am J Gastroenterol 2000;95:3552-3565.
11. Marchesini G, Bianchi G, Amodio P, et al., and the Italian Study Group for Quality of Life in Cirrhosis. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001;120:170-178.
12. Yoo HY, Edwin D, Thuluvath PJ. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites. Am J Gastroenterol 2003;98:1395-1399.
13. Aaronson N, Burnam A, Lohr KN, Patrick DL, Perrin E, Stein REK. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002;11:193-205.
14. Fitzpatrick R, Davey C, Buxton M, Jones D. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998;2:19-44.
15. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996;334:835-840.
16. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-629.
17. Warw JE, Kosinski M, Dewey JE. How to Score Version 2 of the SF-36 Health Survey. Lincoln, RI: Quality Incorporated; 2000.
18. Younossi ZM, Boparai N, McCormick M, Price LL, Guyatt G. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol 2001;96:579-583.
19. Younossi ZM. Chronic liver disease and health-related quality of life. Gastroenterology 2001;120:305-307.
20. Armitage P, Berry G. Statistical Methods in Medical Research. 3rd ed. Oxford: Blackwell Scientific Publications; 1994.
21. Kirk RE. Experimental Design: Procedures for the Behavioral Sciences. 3rd ed. Pacific Grove, Calif: Brooks Cole; 1995.
22. Younossi ZM, Guyatt G. Quality-of-life assessments and chronic liver disease. Am J Gastroenterol 1998;93:1037-1041.
23. Kim WR. Quality of life instruments for liver transplant recipients: too many choices? Liver Transpl 2000;6:784-785.
24. Rannard A, Buck D, Jones DE, James OF, Jacoby A. Assessing quality of life in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2004;2:164-174.
25. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
26. Younossi ZM, McCormick M, Boparai N, Farquhar L, Henderson JM, Guyatt G. The impact of liver transplantation on health-related quality of life. Liver Transpl 2000;6:779-783.